» Articles » PMID: 24715030

Immunopathogenesis of Membranous Nephropathy: an Update

Overview
Publisher Springer
Date 2014 Apr 10
PMID 24715030
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Membranous nephropathy (MN) is a non-inflammatory organ-specific autoimmune disease which affects the kidney glomerulus, resulting in the formation of immune deposits on the outer aspect of the glomerular basement membrane, complement-mediated proteinuria, and severe renal failure in 30% of patients. In the last 10 years, substantial advances have been made in the understanding of the molecular bases of MN, with the identification of several antigens and predisposing genes in children and adults. These ground-breaking findings already have a major impact on diagnosis and monitoring and to some extent on therapies. However, there is evidence that the disease is more complex and involves a variety of antigen-antibody systems and genes involved in immune response, progression, recovery, and protective mechanisms. We herein review these recent findings which open new perspectives of research. Understanding the complex pathogenesis of MN will offer many opportunities for future therapeutic interventions and will hopefully have a major impact on patient care. New insights into the molecular mechanisms of MN may also enlighten the pathogenesis of organ-specific autoimmune diseases.

Citing Articles

Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy.

Hu X, Zhang M, Xu J, Gao C, Yu X, Li X Clin J Am Soc Nephrol. 2024; 19(12):1594-1602.

PMID: 39207845 PMC: 11637703. DOI: 10.2215/CJN.0000000000000555.


A Case of NELL-1-Positive Membranous Nephropathy With Acute Kidney Injury Due to Bilateral Renal Vein Thrombosis.

Kashiv P, Malde S, Gupta S, Dubey S, Sejpal K, Pawar T Cureus. 2024; 16(5):e61230.

PMID: 38939287 PMC: 11210330. DOI: 10.7759/cureus.61230.


The co-occurrence of sarcoidosis and anti-PLA2R-associated membranous nephropathy in a patient with underlying genetic susceptibility.

Ding Y, Yao Y, Wan L, Qu Z, Yu F BMC Nephrol. 2024; 25(1):212.

PMID: 38937663 PMC: 11212182. DOI: 10.1186/s12882-024-03649-0.


Prediction of immunotherapy response in idiopathic membranous nephropathy using deep learning-pathological and clinical factors.

Wei X, Long M, Fan Z, Hou Y, Zhu X, Qu Z Front Endocrinol (Lausanne). 2024; 15:1328579.

PMID: 38524629 PMC: 10958378. DOI: 10.3389/fendo.2024.1328579.


Lectin Complement Pathway Activation is Associated with Massive Proteinuria in PLA2R-Positive Membranous Nephropathy: A Retrospective Study.

Li J, Zhang J, Wang X, Zheng X, Gao H, Jiang S Int J Gen Med. 2023; 16:1879-1889.

PMID: 37213477 PMC: 10195059. DOI: 10.2147/IJGM.S407073.


References
1.
Sato K, Oguchi H, Hora K, Furukawa T, Furuta S, Shigematsu H . Idiopathic membranous nephropathy in two brothers. Nephron. 1987; 46(2):174-8. DOI: 10.1159/000184336. View

2.
Dahnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels J . Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta. 2013; 421:213-8. DOI: 10.1016/j.cca.2013.03.015. View

3.
Ito T, Kitahara K, Umemura T, Ota M, Shimozuru Y, Kawa S . A novel heterophilic antibody interaction involves IgG4. Scand J Immunol. 2010; 71(2):109-14. DOI: 10.1111/j.1365-3083.2009.02353.x. View

4.
Chen S, Chen C, Huang Y, Chan C, Hsieh Y, Yu M . Association of STAT4 polymorphisms with susceptibility to primary membranous glomerulonephritis and renal failure. Clin Chim Acta. 2011; 412(21-22):1899-904. DOI: 10.1016/j.cca.2011.06.020. View

5.
Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z . Cell signals transduced by complement. Mol Immunol. 2004; 41(6-7):583-97. DOI: 10.1016/j.molimm.2004.04.007. View